slides · global inventory
Image
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 119,566
Current window 89,971-90,000
Pages 3,986
Rows per page 30
Component
89,971-90,000 of 119,566
18
Data presented in RMB and US$ for the 2023 period.Ecarx | Results Presentation Deck | 21 slides · Ecarx
Conference presentation Investor relations 1 hit
21
Ecarx | Results Presentation Deck | 21 slidesEcarx | Results Presentation Deck | 21 slides · Ecarx
Conference presentation Investor relations 1 hit
03
Electronic Arts | Results Presentation Deck | 17 slidesElectronic Arts | Results Presentation Deck | 17 slides · Electronic Arts
Conference presentation Investor relations 1 hit
07
The slide uses a matrix-like layout to categorize titles into 'Massive Online Communities', 'Blockbusters & Original IP', and 'EA SPORTS', with a corresponding list of FY24 launch dates.Electronic Arts | Results Presentation Deck | 17 slides · Electronic Arts
Conference presentation Investor relations 1 hit
09
The slide uses a 2x3 grid layout to present six distinct ESG metrics and goals.Electronic Arts | Results Presentation Deck | 17 slides · Electronic Arts
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
16
The slide contains two distinct tables: one by platform (Console, PC & other, Mobile) and one by revenue type (Full game, Live services & other).Electronic Arts | Results Presentation Deck | 17 slides · Electronic Arts
Conference presentation Investor relations Beat · Action1 hit
17
Electronic Arts | Results Presentation Deck | 17 slidesElectronic Arts | Results Presentation Deck | 17 slides · Electronic Arts
Conference presentation Investor relations Beat · Action1 hit
03
The slide is a full-bleed image used to celebrate a company milestone.Eos Energy | Results Presentation Deck | 19 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · Attention1 hit
07
Eos Energy | Results Presentation Deck | 19 slidesEos Energy | Results Presentation Deck | 19 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · Satisfaction1 hit
08
The slide uses a structured process-improvement framework to demonstrate operational maturity.Eos Energy | Results Presentation Deck | 19 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · Satisfaction1 hit
09
Includes a process timeline and specific investment breakdown for capacity expansion.Eos Energy | Results Presentation Deck | 19 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · Satisfaction1 hit
10
Eos Energy | Results Presentation Deck | 19 slidesEos Energy | Results Presentation Deck | 19 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet1 hit
12
The slide uses a timeline-based visual to explain capacity scaling and financial viability.Eos Energy | Results Presentation Deck | 19 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet1 hit
13
Eos Energy | Results Presentation Deck | 19 slidesEos Energy | Results Presentation Deck | 19 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · Action1 hit
04
The slide uses a Gantt-style visualization for drug development stages.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations Loop · Golden Circle1 hit
05
This is a section divider or introductory slide for the product solution.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
06
Includes specific financial breakdown of deal value and R&D funding obligations.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations Beat · Solution1 hit
08
Equillium | Investor Presentation Deck | 39 slidesEquillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations Beat · Solution1 hit
09
Includes a diagram illustrating cytokine-receptor binding and downstream signaling.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations Beat · Solution1 hit
10
Uses a visual comparison framework to illustrate the 'Goldilocks' problem in drug development.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations Beat · Problem1 hit
14
The slide uses a biological mechanism diagram to illustrate how the inhibitor selectively targets specific cytokines (A, D, F) while leaving others unaffected.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
19
The slide uses Western blot data to visually demonstrate the efficacy of EQ101 compared to a standard JAK inhibitor.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
20
Includes before/after clinical photos and a comparative table against Mogamulizumab.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations Beat · Traction1 hit
23
Includes visual longitudinal study (Day 0, 14, 21) and a bar chart comparing efficacy against PBS and Ruxolitinib.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
27
Equillium | Investor Presentation Deck | 39 slidesEquillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
32
The slide uses a process-like diagram to show treatment approaches and highlights the specific mechanism of action (IL-15/IL-21 inhibition) as a superior strategy.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
34
Equillium | Investor Presentation Deck | 39 slidesEquillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
39
Equillium | Investor Presentation Deck | 39 slidesEquillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
09
The slide uses a matrix structure to map indications to benchmarks, specific drug regimens, and trial names, with a footer detailing active clinical trial collaboration and supply agreements (CTCSAs).Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Challenges in current cancer treatment and unmet needsLoop · Logic Chain1 hit
11
The slide combines a biological pathway diagram (left) with a quantitative market sizing table (right).Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Challenges in current cancer treatment and unmet needs1 hit